• Home
• News
• About Us
• Contact

Destruction time for smallpox stores still unknown
by Ashton Daigle on August 25, 2010

This year marks the 30 year anniversary of smallpox being declared eradicated, however, WHO officials are still attempting to pinpoint a destruction time for smallpox stores.

Smallpox vaccine delivered to national stockpile
by Rita Uplend on July 14, 2010

One million doses of the smallpox vaccine IMVAMUNE have been delivered to the U.S. Strategic National Stockpile for use in the event of a smallpox bioterrorism attack on the U.S.

Work underway on single-dose smallpox vaccine
by Tina Redlup on July 2, 2010

Researchers at St. Louis University are experimenting with a new, single-dose smallpox vaccine that could help stop infection during bioterrorist attacks.

U.S. stockpile receives smallpox vaccine
by Ted Purlain on June 12, 2010

The first vaccine to be developed for civilian bioterrorism preparedness programs has been delivered to the U.S. stockpile, according to a CQ Healthbeat News report.

FDA approves smallpox vaccine's delivery
by Ted Purlain on March 22, 2010

Bavarian Nordic, a Danish biotechnology company, has announced that the FDA has decided that all requirements for delivery of the company's smallpox vaccine to the United States government have been met.

SLU seeks 250 people for smallpox study
by Nick Rees on February 5, 2010

As part of its recently announced project to create a smallpox vaccine to fight bioterrorism, Saint Louis University has begun seeking 250 volunteers to inject with smallpox.

Study begins to find more effective manner of fighting smallpox
by Ted Purlain on February 3, 2010

A more effective manner of administering an investigational vaccine for smallpox will be studied by scientists at Saint Louis University's Center for Vaccine Development in a study funded by the National Institute of Health.

SIGA Technologies takes part in Israel's simulated bioattack
by Ted Purlain on January 21, 2010

Representatives from SIGA Technologies took part in Israel's recent "Operation Orange Flame 4" biological defense drill conducted by the Defense Ministry and Health Ministry in conjunction with the Israel Defense Forces Home Front Command.

- NIH grants to aid study of smallpox
by Rita Uplend on January 5, 2010

New grants from the U.S. National Institutes of Health will aid in immunological research on several diseases, including smallpox, which could be used by bioterrorists.

Researchers discover how smallpox kills
by Nick Rees on December 24, 2009

While smallpox has been eradicated from the planet as a naturally occurring virus, it still remains a high level biothreat.

Smallpox vaccine adds to potential biodefense stockpile
by Nick Rees on December 2, 2009

Bavarian Nordic A/S, focusing on biodefense, has announced that it expects to file a new drug submission for Imvamune, its third-generation smallpox vaccine.

Major smallpox vaccine order announcement expected
by Paul Tinder on November 28, 2009

The biodefense company SIGA Technologies, which engages in the discovery, development and commercialization of products for use in defense against biological warfare agents, is expected to make a major announcement.

Nanotherapeutics receives contract to develop smallpox drug
by Mary J. Lewis on October 29, 2009

ALACHUA, Fla. — Nanotherapeutics Inc. has been awarded a $30.9 million, five-year contract from the National Institute of Allergy and Infectious Diseases to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exp

ISBI Conference on de novo Synthesis of Smallpox, Washington DC
by Barry Kellman on July 2, 2009

The communities of experts and officials who focus on bioviolence (the intentional infliction of disease) have long considered smallpox (variola major) to be among the most terrifying bio-agents.

Search

Subscribe to our newsletter

RSS Feed